Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
Article in Canadian Geriatrics Journal (March 2020)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
Article in Health Technology Assessment (November 2018)
Efficacy and safety of biological agents in the older rheumatoid arthritis patients compared to Young: A systematic review and meta-analysis
Article in Seminars in Arthritis and Rheumatism (July 2018)